Poseida Therapeutics Inc (PSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,911 | 40,144 | 81,378 | 164,807 | 62,963 |
| Marketable Securities | 164,695 | 207,057 | 201,115 | 114,178 | 79,594 |
| Receivables | 11,906 | 8,437 | 9,088 | 38,467 | 232 |
| TOTAL | $230,195 | $260,696 | $298,563 | $325,129 | $148,119 |
| Non-Current Assets | |||||
| PPE Net | 21,011 | 22,114 | 21,586 | 21,748 | 22,756 |
| Intangibles | 5,548 | 5,548 | 5,548 | 5,548 | 5,548 |
| Other Non-Current Assets | 24,461 | 25,263 | 26,140 | 28,056 | 29,032 |
| TOTAL | $51,020 | $52,925 | $53,274 | $55,352 | $57,336 |
| Total Assets | $281,215 | $313,621 | $351,837 | $380,481 | $205,455 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,097 | 3,200 | 2,228 | 3,426 | 3,661 |
| Accrued Expenses | 21,695 | 19,580 | 26,068 | 22,073 | 28,699 |
| TOTAL | $49,888 | $48,690 | $53,885 | $48,968 | $40,093 |
| Non-Current Liabilities | |||||
| Long Term Debt | 58,402 | 58,322 | 58,250 | 58,162 | 58,065 |
| Deferred Revenues | 20,233 | 20,090 | 19,723 | 16,732 | 1,047 |
| Other Non-Current Liabilities | 29,163 | 29,983 | 30,774 | 31,696 | 32,631 |
| TOTAL | $96,026 | $107,366 | $110,357 | $115,200 | $99,562 |
| Total Liabilities | $145,914 | $156,056 | $164,242 | $164,168 | $139,655 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,916 | 86,776 | 86,527 | 85,949 | 85,776 |
| Common Shares | 9 | 9 | 9 | 9 | 6 |
| Retained earnings | -537,164 | -509,708 | -470,861 | -437,543 | -507,952 |
| Other shareholders' equity | -280 | 2 | -149 | -144 | -132 |
| TOTAL | $135,301 | $157,565 | $187,595 | $216,313 | $65,800 |
| Total Liabilities And Equity | $281,215 | $313,621 | $351,837 | $380,481 | $205,455 |